Montelukast clinical trials
Also written Singulair and MK0476.
How each study uses montelukast is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the montelukast studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 20 Feb 1998 · SINGULAIR · NDA 020829 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
225 studies that test it; most in 2007 (22)
| Year | Studies |
|---|---|
| 1995 | 1 |
| 1997 | 1 |
| 1999 | 2 |
| 2000 | 4 |
| 2001 | 7 |
| 2002 | 3 |
| 2003 | 10 |
| 2004 | 8 |
| 2005 | 17 |
| 2006 | 18 |
| 2007 | 22 |
| 2008 | 10 |
| 2009 | 4 |
| 2010 | 18 |
| 2011 | 12 |
| 2012 | 10 |
| 2013 | 9 |
| 2014 | 6 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 3 |
| 2018 | 5 |
| 2019 | 8 |
| 2020 | 6 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 7 |
| 2024 | 2 |
| 2025 | 4 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 80 · Other 147
Organon and Co (46) · GlaxoSmithKline (5) · Dr. Reddy's Laboratories Limited (5) · Roxane Laboratories (4) · Medical University of Lodz (4) · University of Colorado, Denver (4) · Assiut University (3) · Hanmi Pharmaceutical Company Limited (3)
Often tested with
Tested in the same studies.
Fluticasone (9) · Salmeterol Xinafoate (7) · Budesonide (6) · Loratadine (5) · Levocetirizine (4) · Azithromycin (3) · Prednisone (3) · Flurbiprofen (2)
Related medicines
As reviewed, each with the page that says it.
- One of Leukotriene modifiers source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 7, 2 in phase 3
Studies that test montelukast, phase 3 first.
- Jan 2027Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue PatientsPhase 2/3 · Phramongkutklao College of Medicine and Hospital
- Feb 2027Efficacy of Montelukast on STEMl PatientsPhase 3 · Shanghai Zhongshan Hospital
- Feb 2027Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic RhinitisPhase 4 · Liaquat National Hospital & Medical College
- Feb 2027Effect of Montelukast on Kidney and Vascular Function in Type 1 DiabetesPhase 4 · University of Colorado, Denver
- May 2027Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial InfarctionPhase 2 · October 6 University
- Jun 2027MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)Early Phase 1 · Austin V Stone
- Jun 2027PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaPhase 1/2 · Duke University
Studies
Open first, then newest update. How each study uses montelukast is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 227
- SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 DiabetesRecruitingEarly Phase 1University of Colorado, DenverNCT07409714Written as MontelukastHow we know
- Clinical Evaluation of Montelukast in Veterans With Gulf War IllnessRecruitingPhase 1Baylor College of MedicineNCT05992311Written as MontelukastHow we know
- Evaluating The Role Of Montelukast In Management Of Acute BronchiolitisRecruitingPhase 2Pakistan Institute of Medical SciencesNCT07770464Written as MontelukastHow we know
- PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary DysplasiaRecruitingPhase 1/2Duke UniversityNCT07101640Written as montelukast 4 mg granuleHow we know
- MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 DiabetesNot yet recruitingPhase 4University of Colorado, DenverNCT07685886Written as MontelukastHow we know
- Effect of Montelukast on Kidney and Vascular Function in Type 1 DiabetesRecruitingPhase 4University of Colorado, DenverNCT05498116Written as MontelukastHow we know
- MOntelukast as a Potential CHondroprotective Treatment Following Anterior Cruciate Ligament Reconstruction (MOCHA Trial)RecruitingEarly Phase 1Austin V StoneNCT04572256Written as MontelukastHow we know
- Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial InfarctionRecruitingPhase 2October 6 UniversityNCT07537868Written as Montelukast 10 Mg Oral TabletHow we know
- Comparison of Antihistamine and Antileukotriene Add-On Therapy to Intranasal Corticosteroid in Allergic RhinitisNot yet recruitingPhase 4Liaquat National Hospital & Medical CollegeNCT07532993Written as Montelukast 10 mgHow we know
- Efficacy of Montelukast on STEMl PatientsRecruitingPhase 3Shanghai Zhongshan HospitalNCT07320625Written as MontelukastHow we know
- Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue PatientsRecruitingPhase 2/3Phramongkutklao College of Medicine and HospitalNCT06747130Written as MontelukastHow we know
- Lipid Mediators & Cancer: Montelukast, SPM, and AlmondsNot yet recruitingEarly Phase 1University of South FloridaNCT06887673Written as Montelukast 10 Mg Oral TabletHow we know
- Serum Intercellular Adhesion Molecule -1 in Acne Vulgaris Patients : Effect of MontelukastNot yet recruitingPhase 3South Valley UniversityNCT06340984Written as Montelukast 10 Mg Oral TabletHow we know
- SMILES: Study of Montelukast in Sickle Cell DiseaseRecruitingPhase 2/3Great Ormond Street Hospital for Children NHS Foundation TrustNCT04351698Written as MontelukastHow we know
- Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing ChinaNot yet recruitingPhase 4Chinese University of Hong KongNCT04762472Written as Montelukast Oral TabletHow we know
- Effect of Some Drugs on Rheumatoid Arithritis ActivityRecruitingPhase 3Sherief Abd-ElsalamNCT03770923Written as MontelukastHow we know
- Montelukast in Parkinson DiseaseCompletedPhase 2/3Mostafa BahaaNCT06113640Written as MontelukastHow we know
- Treating Exacerbations of Asthma With Oral Montelukast in ChildrenCompletedPhase 2Vanderbilt University Medical CenterNCT05819541Written as Montelukast Oral GranulesHow we know
- Does Montelukast Decrease Post Adenotonsillectomy Pain in ChildrenCompletedPhase 3Children's Hospital Medical Center, CincinnatiNCT02793375Written as MontelukastHow we know
- A Pilot Study of Mirabegron and Montelukast in Cirrhotic PatientsCompletedPhase 4Kafrelsheikh UniversityNCT07533565Written as Montelukast 10 mgHow we know
See all 227 studies that test montelukast →
Given beside what is tested · 27 — montelukast is usual care or a partner of the new treatment
- Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE TrialRecruitingPhase 4Emory UniversityNCT07101445Written as MontelukastHow we know
- BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)RecruitingPhase 2Dana-Farber Cancer InstituteNCT05922761Written as MontelukastHow we know
- Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple MyelomaRecruitingPhase 2Benjamin T Diamond, MDNCT05896228Written as MontelukastHow we know
- Premedication to Reduce Amivantamab Associated Infusion Related ReactionsActive, not recruitingPhase 2Janssen Research & Development, LLCNCT05663866Written as MontelukastHow we know
- A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaActive, not recruitingPhase 2SanofiNCT06356571Written as MontelukastHow we know
- A Clinical Trial to Evaluate MK-4208/Embibatinib in Healthy Adult Participants (MK-4208-001/Embibatinib-1014)CompletedPhase 1Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)NCT07838987Written as MontelukastHow we know
- SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMMActive, not recruitingPhase 3SanofiNCT05405166Written as MontelukastHow we know
- A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple MyelomaActive, not recruitingPhase 2University of MiamiNCT04268498Written as MontelukastHow we know
- Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host DiseaseCompletedPhase 2National Cancer Institute (NCI)NCT04294641Written as MontelukastHow we know
- A Study to Investigate Subcutaneous Isatuximab in Combination With Carfilzomib and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaActive, not recruitingPhase 2SanofiNCT05704049Written as MontelukastHow we know
- A Prospective Study to Investigate Safety and Tolerability of Shorter Infusion of FabrazymeCompletedPhase 4SanofiNCT06019728Written as MontelukastHow we know
- A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple MyelomaCompletedPhase 1Janssen Research & Development, LLCNCT01998971Written as MontelukastHow we know
- To Evaluate the Efficacy and Safety of TQC3564 Tablets in the Treatment of Persistent Allergic RhinitisTerminatedPhase 1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.NCT05607446Written as TQC3564 tablets, montelukast sodium tabletsHow we know
- Effects of a Orally Inhaled Fluticasone Furoate on Growth Velocity in Prepubertal, Paediatric Subjects With Asthma Over a YearCompletedPhase 4GlaxoSmithKlineNCT02889809Written as MontelukastHow we know
- A Study to Evaluate the Drug-drug Interaction Potential of BMS-986196 in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05852769Written as MontelukastHow we know
- Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus SurgeryCompletedPhase 4First Affiliated Hospital, Sun Yat-Sen UniversityNCT02110654Written as MontelukastHow we know
- Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With AsthmaCompletedPhase 3GlaxoSmithKlineNCT02483975Written as MontelukastHow we know
- Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011)CompletedPhase 2Merck Sharp & Dohme LLCNCT01624974Written as Montelukast (ML)How we know
- Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015)CompletedPhase 2Merck Sharp & Dohme LLCNCT02720081Written as Montelukast 10 mgHow we know
- Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and PravastatinCompletedPhase 1Bristol-Myers SquibbNCT03131973Written as MontelukastHow we know
Showing 20 of 27.
As the comparator · 20 — what is tested is compared with montelukast
- A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate AsthmaCompletedPhase 3Hoffmann-La RocheNCT02104674Written as MontelukastHow we know
- Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)CompletedPhase 4Organon and CoNCT00394355Written as montelukastHow we know
- BI 671800 in Asthmatic Patients on Inhaled CorticosteroidsCompletedPhase 2Boehringer IngelheimNCT01103349Written as MontelukastHow we know
- Study of the Effect of Mometasone Furoate/Formoterol (MF/F), Montelukast and Beclomethasone Dipropionate (BDP) on Plasma Cortisol Levels of Children 5-11 Years Old With Persistent Asthma (P05574)WithdrawnPhase 2Organon and CoNCT01615874Written as Montelukast tablets 5 mg (4 mg for children 5 years of age)How we know
- Dose Finding Study for QAW039 in AsthmaCompletedPhase 2Novartis PharmaceuticalsNCT01437735Written as MontelukastHow we know
- Montelukast and Loratadine in Children With AsthmaCompletedPhase 3Innovacion y Desarrollo de Estrategias en SaludNCT03372473Written as MontelukastHow we know
- A Study to Evaluate Efficacy and Safety of ADC3680 in Subjects With Inadequately-Controlled AsthmaCompletedPhase 2Pulmagen TherapeuticsNCT01730027Written as montelukastHow we know
- Dose Ranging Study Evaluating the Efficacy and Safety of GSK2190915 Administered Once DailyCompletedPhase 2GlaxoSmithKlineNCT01147744Written as Montelukast 10mgHow we know
- Safety and Efficacy Study Adding GSK2190915 to Mid-dose Inhaled Corticosteroid/Long Acting Beta Agonist Combination Treatment for AsthmaCompletedPhase 2GlaxoSmithKlineNCT01248975Written as Montelukast 10mg QD (PM)How we know
- A Study to Evaluate the Effectiveness of JNJ 40929837 for the Treatment of Asthma Using a Bronchial Allergen Challenge ModelCompletedPhase 2Johnson & Johnson Pharmaceutical Research & Development, L.L.C.NCT01241422Written as MontelukastHow we know
- Fractional Concentration of Exhaled NO(FENO) to Direct Montelukast Treatment of Sub-acute CoughStatus unknownNot applicableBeijing Chao Yang HospitalNCT02303600Written as MontelukastHow we know
- Safety and Efficacy of YHD001 in AsthmaCompletedPhase 2Yuhan CorporationNCT01424124Written as SingulairHow we know
- Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of SeasonCompletedPhase 2Boehringer IngelheimNCT01007721Written as montelukast 10 mg tabletHow we know
- A Placebo and Active Controlled Study of ONO-6950 in Asthmatic PatientsCompletedPhase 2Ono Pharma USA IncNCT01536041Written as MontelukastHow we know
- Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent AsthmaCompletedPhase 2SK Chemicals Co., Ltd.NCT00936624Written as montelukastHow we know
- A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With AsthmaCompletedPhase 2Ono Pharma USA IncNCT01551147Written as MontelukastHow we know
- Management of Asthma in School-age Children on TherapyCompletedPhase 4Professor Warren LenneyNCT01526161Written as MontelukastHow we know
- A Study To Assess The Effect Of PF-03893787 On Lung Function Following An Allergen Challenge In Asthmatic SubjectsCompletedPhase 1PfizerNCT00856687Written as MontelukastHow we know
- Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, ChildrenCompletedPhase 4AstraZenecaNCT00641472Written as Montelukast SodiumHow we know
- Short- and Long Term Growth in Children With AsthmaCompletedPhase 4Children´s Clinic, RandersNCT00380484Written as MontelukastHow we know
Codes
What other systems call montelukast · ClinicalTrials.gg INT003850
- MeSH (NLM) C093875montelukastConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) MHM278SD3EMONTELUKASTConfirmed FDA, NLM, Wikidata
- RxNorm 88249Confirmed FDA, Wikidata
- Wikidata Q417767montelukastConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66189MontelukastOne source FDA
- DrugBank DB00471One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C093875 | montelukast | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | MHM278SD3E | MONTELUKAST | Confirmed FDA, NLM, Wikidata |
| RxNorm | 88249 | — | Confirmed FDA, Wikidata |
| Wikidata | Q417767 | montelukast | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66189 | Montelukast | One source FDA |
| DrugBank | DB00471 | — | One source Wikidata |
Also registered as montelukast sodium (UNII U1O3J18SFL · RxNorm 115713).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.